Clinical Trial

A Phase 2A Trial of DT402 for Autism Spectrum Disorder

Name: A Phase 2A Trial of DT402 for Autism Spectrum Disorder — clinical trial record (NCT07303907)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-12-23; most recent amendment 2026-03-31.

Trial Details

NCT Number	NCT07303907
Lead Sponsor	Definium Therapeutics US, Inc.
Conditions	Autism Spectrum Disorder, ASD
Enrollment	20 participants
Start Date	2025-12-03
Primary Completion	2027-08 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-04-06